Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:15 PM
Ignite Modification Date:
2025-12-24 @ 7:15 PM
NCT ID:
NCT04424303
Eligibility Criteria:
Inclusion Criteria:
* Patients of 18 years old or above
* Patients with confirmed diagnosis of moderate to severe ulcerative colitis
* Patients for whom gastroenterologist decides to initiate treatment with tofacitinib as per the French SmPC
* Patients informed about the study procedures and receiving an information letter signed by the investigator
Exclusion Criteria:
* Patients who have already received tofacitinib treatment before baseline
* Patients that fulfill any of the contrindications according to the latest version of the SmPC
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04424303
Study Brief:
Protocol Section:
NCT04424303